Covance bolsters pharmacovigilance services with Sciformix acquisition

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/marchmeena29)
(Image: Getty/marchmeena29)
Covance has acquired Sciformix in a deal that augments the CRO’s pharmacovigilance capabilities for post-approval safety solutions and expands its global footprint.

Covance, LabCorp’s contract research organization (CRO) business, has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions.

“Sciformix enhances Covance’s offering, particularly in post-approval pharmacovigilance. Its capabilities are complementary with Covance’s existing Drug and Device Safety Solutions and Adjudication as well as Covance Market Access (CMA),”​ Sue Maynard, vice president, corporate communications, LabCorp, told Outsourcing-Pharma.com.

Sciformix provides post-marketing safety and risk management, clinical development support services, regulatory affairs and operations, technology services, and real-world evidence (RWE) solutions.

Maynard said: “The need for post-approval solutions is driven by many factors including momentum in new product launches, and increasing expectations for safety monitoring during later stages of development and post approval.”

Sciformix – which Maynard said will “largely operate as an independent business unit”​ – has 1,100 employees are based in Asia, further expanding Covance’s global footprint.

Terms of the transaction were not disclosed.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars